GEPIA survival analysis confirmed that increased expression of NDUFA6, NDUFC1, SDHA, CYB5A, SLC25A12, ETFB and CPT1A significantly correlated with shorter OS of AML patients (Fig. 1H). Here, CYB5A is linked to acute myeloid leukemia.